Rapid neurological deterioration in a patient with multiple sclerosis treated with systemic interleukin-2 and interferon-alpha 2b for metastatic renal cell carcinoma.
Kinkel
R P
RP
Rudick
R A
RA
Ransohoff
R M
RM
D002292:Carcinoma, Renal Cell / Q000473:pathology*; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000473:pathology*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000473:pathology*
D016898:Interferon-alpha; D007376:Interleukin-2